Short communicationThe neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1
References (15)
- et al.
2-Amino-6-trifluoromethoxyl benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. II. Biochemical properties
Neuropharmacology
(1985) - et al.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo
Neurosci. Lett.
(1992) - et al.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes
Eur. J. Pharmacol.
(1993) - et al.
Ibotenic acid stimulates D-[3H]aspartate release from cultured cerear granule cells
Neurosci. Lett.
(1989) - et al.
A grease-gap method for studying the excitatory amino acid pharmacology of CA1 hippocampal pyramidal cells
J. Neurosci. Methods
(1989) - et al.
Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87
Brain Res.
(1992) - et al.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid transmission. I. Anticonvulsant properties
Neuropharmacology
(1985)
There are more references available in the full text version of this article.
Cited by (227)
Anti-allodynic and promotive effect on inhibitory synaptic transmission of riluzole in rat spinal dorsal horn
2021, Biochemistry and Biophysics ReportsThe molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS
2019, Journal of Biological ChemistryCitation Excerpt :The latter are found in the brain and spinal cord of affected individuals as intracellular inclusions. To date, two drugs have been approved for treatment of ALS: riluzole (7) and edaravone (8). These drugs slow disease progression mildly but do not alter substantially the disease course.
Effects of riluzole on spinal seizure-like activity in the brainstem-spinal cord preparation of newborn rat
2017, Neuroscience ResearchElectrochemical detection of the neurotransmitter glutamate and the effect of the psychotropic drug riluzole on its oxidation response
2024, Analytical and Bioanalytical ChemistryTherapeutic targeting of ALS pathways: Refocusing an incomplete picture
2023, Annals of Clinical and Translational Neurology
- 1
Present address: Synergen, Inc., 1885 33rd Street, Boulder, CO 80301, USA.
Copyright © 1993 Published by Elsevier B.V.